Dr. Jean-Paul Abboud, MD, PhD

Dr. Abboud practices at Highly Artistic Surgery, Inc in Poway, California.

Dr. Abboud's NPI, 1760776728, was assigned on June 7, 2011. Dr. Abboud graduated from Rutgers Robert Wood Johnson Medical School in 2011. Dr. Abboud holds California license A124875.

Dr. Abboud's primary practice is Highly Artistic Surgery, Inc, at 15725 Pomerado Rd, Poway, CA 92064 in San Diego County. The practice phone is (858) 487-3742.

Dr. Abboud's primary practice is Highly Artistic Surgery, Inc in Poway, California. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Abboud to 4 more medical groups, 2 group practices and clinics and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abboud practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Abboud's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Abboud is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Abboud's licenses on file in 3 states: California, Texas and West Virginia.

Dmand AI lists cold sores or genital herpes, dry eye, eye infection or inflammation, eyelid inflammation and scleritis among the conditions Dr. Abboud treats.

CMS data shows 887 Medicare services from Dr. Abboud across 13 procedure codes in 2024, for 279 Medicare patients. Medicare paid $71,650 for them.

CMS counts 279 Medicare patients who saw Dr. Abboud in 2024. The largest group is 65 to 74, with 122 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Abboud's median patient age at 70, with 48% women.

In 2024, Dr. Abboud wrote 249 Medicare Part D claims for 154 patients. 48% of them were for generic drugs. CMS names the drug for 200 of them, across 3 drugs with 11 or more claims each, at $1,859 in total drug cost. In 2023, CMS named 178 claims across 3 drugs.

Dr. Abboud accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of melanoma (skin cancer) excision by Dr. Abboud, more than 69% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Abboud, published from 2015 to 2025. 2015 was the busiest year, with 2. Dr. Abboud has published most often in Ophthalmic Plast Reconstr Surg. Dr. Abboud's most frequent co-authors are Don O. Kikkawa, MD, Bobby S. Korn, MD and Masih Ahmed, MD.

CMS Open Payments shows 38 general payments to Dr. Abboud from 12 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 98% of the total. Horizon Pharma plc paid the most, $744.

Dmand AI lists 1 award for Dr. Abboud, most recently Outstanding Teacher Award in 2014.

Dr. Abboud graduated from Rutgers Robert Wood Johnson Medical School in 2011. Dr. Abboud is a member of AAO, ACS and American Society of Ophthalmic Plastic and Reconstructive Surgery.

Dr. Abboud is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.